Trial Testing the Effect of Strategies on Performance of Brief Intervention Programmes for Harmful Alcohol Consumption

NCT01501552 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2016-09-07

No results posted yet for this study

Summary

The overall objective is to study if training and support, financial reimbursement and referral to an internet based brief intervention programme, singly or in combination, may increase implementation of evidence based methods of identification and brief intervention for excessive alcohol consumption in routine primary health care.

Conditions

  • Alcoholism

Interventions

OTHER

Training and support (T&S)

Two face-to-face educational meetings of at least one hour and a maximum of 2 hours, and one telephone support call of at least ten minutes and a maximum of 30 minutes. The telephone call will be offered to one of the GPs ('leader'). Depending on the needs of the PHCU, one additional face to face training (1 to 2 hours) may be offered. The time interval between meetings will be on average 2 weeks. The training sessions will address improving knowledge, skills, attitudes, and perceived barriers and facilitators by combining theory and practice-based training.

OTHER

Financial incentive

Groups will receive a financial incentive depending on their screening and brief intervention activities. They will be paid for the performance, with the country dependent system of pay (fee for item or fee for achieving set rates) and based on normal practices and financial rates for financial incentives for clinical preventive activities.

OTHER

E-SBI (online screening and brief intervention)

Referring identified at-risk patients to an approved e-SBI programme, which will be either country specific (where these exist) or based on the WHO e-SBI programme (Poland).

Sponsors & Collaborators

  • European Commission

    collaborator OTHER
  • Stichting Katholieke Universiteit

    collaborator OTHER
  • University of Newcastle Upon-Tyne

    collaborator OTHER
  • King's College London

    collaborator OTHER
  • Göteborg University

    collaborator OTHER
  • Linkoeping University

    collaborator OTHER_GOV
  • Department of Health, Generalitat de Catalunya

    collaborator OTHER_GOV
  • State Agency for Solving Alcohol Problems

    collaborator OTHER
  • University College, London

    collaborator OTHER
  • Maastricht University

    collaborator OTHER
  • Pomeranian Medical University Szczecin

    collaborator OTHER
  • Fundacion Clinic per a la Recerca Biomédica

    lead OTHER

Principal Investigators

  • Preben - Bendtsen, MD · Linkoeping University

  • Fredrik - Spak, MD · Göteborg University

  • Peter - Anderson, MD · Maastricht University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
FACTORIAL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-05-31
Completion
2014-12-31

Countries

  • Netherlands
  • Poland
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01501552 on ClinicalTrials.gov